J Korean Diabetes.  2020 Jun;21(2):55-58. 10.4093/jkd.2020.21.2.55.

Diabetes and Viral Diseases

• Kim S

• KMID: 2503959
• DOI: http://doi.org/10.4093/jkd.2020.21.2.55

Abstract

Patients with diabetes are more susceptible to viral diseases, which are more likely to progress to severe cases in such patients. Diabetes and hyperglycemia have been reported to be major risk factors and poor prognostic factors for 2019 flu, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the currently ongoing coronavirus disease-2019 (COVID-19). However, it is not clear yet whether diabetes itself leads to higher risk and becomes a poor prognostic factor for viral diseases or if the real main factors are actually cardiovascular and renal complications that often accompany diabetes. On the other hand, viral diseases have frequently been suggested to be one cause or a contributing factor to develop diabetes. Two typical examples are the association between enteroviruses such as Coxsackie B virus and type 1 diabetes and the relationship between hepatitis C virus and type 2 diabetes. Recently, there has been research on the potentiality of changes in the intestinal microflora being a cause for diabetes, and there is evidence to suggest that intestinal virome affects intestinal microbiota. There has also been a claim that extracellular vesicles secreted by

Keyword

Cosxackie B viruses; Diabetes mellitus; Enteroviruses; Extracellular vesicles; Hepatits C; Microbiome; Viral diseases

Reference

1. Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract 2020. doi: 10.1016/j.diabres.2020.108142. [Epub ahead of print].

2. Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019; 11:762.

3. Gastaldi G, Goossens N, Clément S, Negro F. Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: a review. J Adv Res. 2017; 8:149–59.

4. Santiago-Rodriguez TM, Hollister EB. Human virome and disease: high-throughput sequencing for virus discovery, identification of phage-bacteria dysbiosis and development of therapeutic approaches with emphasis on the human gut. Viruses. 2019; 11:656.

5. Choi Y, Kwon Y, Kim DK, Jeon J, Jang SC, Wang T, Ban M, Kim MH, Jeon SG, Kim MS, Choi CS, Jee YK, Gho YS, Ryu SH, Kim YK. Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle. Sci Rep. 2015; 5:15878.

6. Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis . J Immunol Res. 2019; 2019:6196532.

7. Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K, Venketaraman V. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially Mycobacterium tuberculosis . J Clin Med. 2019; 8:2219.

8. Shenoy A, Ismaily M, Bajaj M. Diabetes and COVID-19: a global health challenge. BMJ Open Diabetes Res Care. 2020; 8:e001450.

9. Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020. doi: 10.1016/S2213-8587(20)30152-2. [Epub ahead of print].

10. Chelakkot C, Choi Y, Kim DK, Park HT, Ghim J, Kwon Y, Jeon J, Kim MS, Jee YK, Gho YS, Park HS, Kim YK, Ryu SH. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018; 50:e450.